Cas:87223-77-6 Ethyl 3-amino-1H-indole-2-carboxylate manufacturer & supplier

Chemical Name:Ethyl 3-amino-1H-indole-2-carboxylate

CAS.NO:87223-77-6

Synonyms:Ethyl 3-amino-1H-indole-2-carboxylate;1H-Indole-2-carboxylic acid, 3-amino-, ethyl ester

Molecular Formula:C₁₁H₁₂N₂O₂

Molecular Weight:204.225

HS Code:2933990090

Physical and Chemical Properties:

Melting point:153-154ºC

Boiling point:400.1±25.0 °C at 760 mmHg

Density:1.3±0.1 g/cm3

Index of Refraction:1.669

PSA:68.11000

Exact Mass:204.089874

LogP:2.94

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Ethyl 3-amino-1H-indole-2-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1H-Indole-2-carboxylic acid, 3-amino-, ethyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Ethyl 3-amino-1H-indole-2-carboxylate Use and application,1H-Indole-2-carboxylic acid, 3-amino-, ethyl ester technical grade,usp/ep/jp grade.

Related News: From the perspective of the overall life cycle of generic drugs from R & D to sales, with the expiration of patents, the business model for the production and marketing of generic pharmaceutical raw materials has changed, demand has increased, business potential has been realized quickly, and gross profit margins have shown a downward trend. Ethyl 3-amino-1H-indole-2-carboxylate manufacturer In March 2021, Reuters reported that a former Lilly human resources officer, Amrit Mula, had identified internally some of the same violations later documented by the FDA. Mula was forced out of the company in early 2019 after Lilly executives sought to downplay her findings, according to a letter demanding compensation for damages that her attorneys sent to the company. Ethyl 3-amino-1H-indole-2-carboxylate supplier In March 2021, Reuters reported that a former Lilly human resources officer, Amrit Mula, had identified internally some of the same violations later documented by the FDA. Mula was forced out of the company in early 2019 after Lilly executives sought to downplay her findings, according to a letter demanding compensation for damages that her attorneys sent to the company. Ethyl 3-amino-1H-indole-2-carboxylate vendor The move could force international drugmakers to further cut prices and enable copycat medicines to replace imported off-patent brands at faster pace. Ethyl 3-amino-1H-indole-2-carboxylate factory A combination of Imbruvica and AbbVie and Roche’s Venclexta slashed the risk of cancer progression or death by 78.4% compared with a cocktail of Roche’s Gazyva and the chemotherapy chlorambucil in previously untreated CLL. The data, from the phase 3 GLOW trial, were shared at the European Hematology Association (EHA) annual meeting.